GERNGeron Corporation

$1B

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$29,000-60.3% YoY

Gross Profit

$29,000100.0% margin

Operating Income

-$52M-179141.4% margin

Net Income

-$49M-169748.3% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

+38.1%

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$30M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$415M

Total Liabilities

$117M

Stockholders' Equity

$298M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29,000	$73,000	-60.3%
Gross Profit	$29,000	$73,000	-60.3%
Operating Income	-$52M	-$28M	-85.7%
Net Income	-$49M	-$28M	-75.1%

GERN Q2 2023 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena